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Alcohol consumption and the reinstatement of alcohol-seeking rely on glutamate and
GABA transmission. Modulating these neurotransmitters may be a viable treatment
strategy to prevent alcohol relapse. N-acetylcysteine (NAC) and the antibiotic ceftriaxone
(CEF) alter the glial reuptake and release of glutamate while the antibiotic cefazolin
(CEFAZ) modulates GABA signaling without affecting glutamate. Here, we used the
extinction-reinstatement model of relapse to test the ability of these compounds
to attenuate the reinstatement of alcohol-seeking. Male Sprague-Dawley rats were
trained to self-administer 20% (v/v) alcohol in the home cage using an intermittent
schedule (24 h on, 24 h off) for 12 sessions. Subsequently, animals self-administered
alcohol during daily 45-min operant sessions for 26 sessions, followed by extinction
training. We tested whether chronic administration of NAC, CEF, or CEFAZ attenuated
the cue-primed reinstatement of alcohol-seeking. CEF and CEFAZ attenuated cue-
primed reinstatement of alcohol-seeking while NAC had no effect. We subsequently
investigated whether CEF and CEFAZ alter the self-administration of sucrose and chow
pellets and if CEFAZ attenuates the reinstatement of cocaine-seeking. The operant self-
administration of regular chow and sucrose was not altered by either CEF or CEFAZ.
CEFAZ had no effect on cocaine reinstatement, a behavior that has been strongly tied to
altered glutamate homeostasis in the nucleus accumbens. Thus the ability of CEFAZ to
attenuate alcohol reinstatement likely does not involve the glial modulation of glutamate
levels. The dampening of GABA transmission may be a common mechanism of action
of cefazolin and ceftriaxone.
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Introduction
Alcoholism or alcohol dependence is a chronic, progressive disease which results from an inability
to regulate drug-seeking behavior. Approximately 17 million Americans are dependent on alco-
hol (NIH, 2006), resulting in signiﬁcant legal and medical costs to society totaling an estimated
$184 billion per year (Kenna et al., 2004). At present, only disulﬁram, naltrexone, and acamprosate
are approved by the Food and Drug Administration to treat alcoholism. However, the ability of
these medications to reduce the risk of relapse is modest (Heilig and Egli, 2006; Soyka and Roesner,
2006) and thus there is a need to develop more targeted pharmacological treatments for alcohol
addiction.
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Animal models of relapse permit the identiﬁcation of the
underlying neurobiology of alcohol relapse in humans and thus
the targeted development of pharmacotherapies. Relapse is mod-
eled in animals with the reinstatement paradigm, where ani-
mals are trained to self-administer drug in an operant cham-
ber. The drug-seeking response is extinguished and reinstated
with one of the stimuli known to cause relapse in humans
such as stress, cues associated with drug delivery, or the drug
itself (Epstein et al., 2006). It has proven challenging to get
laboratory rats to voluntarily consume doses of alcohol rel-
evant to human alcohol addiction. Various procedures have
been attempted to increase oral consumption of alcohol in
rodents, such as sucrose fading (Samson, 1986), food and water-
deprivation (Meisch and Thompson, 1972), alcohol vapor expo-
sure (Walker and Koob, 2007; Walker et al., 2008), and the use
of rat strains selectively bred for high preference to alcohol
(Samson et al., 1998; Vacca et al., 2002). Since its introduction in
the 1980s, sucrose fading was largely adopted as the chief method
of inducing rodents to self-administer alcohol in an operant set-
ting (Samson, 1986). While sucrose fading yields high alcohol
consumption in the presence of sucrose, drinking drops sharply
when the sweetener is removed (Samson, 1986; Koob and Weiss,
1990; Samson et al., 1999; Carrillo et al., 2008). Additionally,
sucrose has addictive properties itself (Colantuoni et al., 2002;
Avena et al., 2008), possibly contributing to the motivation to
consume sweetened alcohol. One method of inducing high
amounts of unsweetened alcohol consumption in rodents is
the intermittent access to alcohol (IAA) procedure in which
rodents are provided 24 h access to alcohol followed by a 24 h
period with no access (Wayner and Greenberg, 1972; Wise, 1973;
Pinel and Huang, 1976). Simms et al. (2008) recently resurrected
this model and induced levels of drinking (20% alcohol v/v)
in the 5–8 g/kg/day range in Wistar and Long-Evans strains.
Furthermore, Simms et al. (2010) adapted the IAA paradigm
to an operant self-administration model and engendered high
levels of alcohol-seeking in the operant chamber after using
14 h operant sessions on intermittent days (MWF), followed
by shorter (30–45 min) daily sessions in the operant cham-
ber. Here, we modiﬁed this method to eliminate the use of
14 h operant sessions and trained animals in the operant
chamber only during daily 45-min sessions for 26 sessions
(MTWRF).
We then sought to test the ability of translational compounds
which modulate glutamate and/or GABA transmission to atten-
uate the cue-primed reinstatement of alcohol-seeking. Glutamate
transmission in general and speciﬁcally in the nucleus accum-
bens (NAs) and amygdala is strongly implicated in cue-induced
alcohol reinstatement. During the cue-primed reinstatement of
extinguished operant alcohol-seeking, synaptic glutamate release
increases in the NA and the amygdala (Gass et al., 2011). Thus, it
follows that both systemic and intra-NA or intra-amygdala infu-
sion of antagonists to post-synaptic glutamate receptors atten-
uate alcohol reinstatement (e.g., Backstrom and Hyytia, 2004;
Backstrom et al., 2004; Sanchis-Segura et al., 2006; Sinclair et al.,
2012).
The pharmacological manipulations which prevent relapse to
alcohol-seeking also prevent the reinstatement of cocaine-seeking
(for review see Kalivas et al., 2009; Knackstedt and Kalivas, 2009).
Following cocaine self-administration and withdrawal, evidence
exists for altered glutamate homeostasis, deﬁned as the homeo-
static regulation of synaptic and extrasynaptic glutamate levels
and signaling. Glutamate homeostasis in the accumbens is com-
plex and regulated by multiple mechanisms, including by the
major glutamate transporter GLT-1 and by system xc-. System
xc- exchanges extracellular cystine for intracellular glutamate,
thereby contributing the majority of basal extrasynaptic gluta-
mate in the accumbens (Baker et al., 2002). The catalytic sub-
unit of system xc- is the protein xCT and the hallmarks of
altered glutamate homeostasis after cocaine include a reduc-
tion in expression and function of both GLT-1 and xCT/system
xc- (Knackstedt et al., 2010; Trantham-Davidson et al., 2012).
Based on the widespread involvement of various types of glu-
tamate receptors in alcohol relapse, it is likely that gluta-
mate homeostasis is altered following alcohol consumption as
well.
Modulation of GABA transmission also impacts alco-
hol consumption and reinstatement. GABAA antagonists and
inverse agonists decrease alcohol consumption (see review by
McBride and Li, 1998) and operant self-administration of alco-
hol (Samson et al., 1987).The GABAB (autoreceptor) agonist
baclofen decreases self-administration in non-dependent rats
(Janak and Michael Gill, 2003). Conversely, allopregnanolone,
an endogenous neurosteroid which has also been shown
to be a potent positive modulator of GABAA receptors,
dose-dependently induces the reinstatement of alcohol-seeking
(Nie and Janak, 2003; Finn et al., 2008).
We hypothesized that glutamate homeostasis is altered post-
alcohol administration, and restoring homeostasis would reverse
alcohol-induced plasticity and thereby attenuate the reinstate-
ment of alcohol-seeking. It is possible to restore glutamate
homeostasis and reverse cocaine-induced pathologies in synaptic
plasticity following with N-acetylcysteine (NAC; Moussawi et al.,
2009, 2011) or ceftriaxone (CEF; Trantham-Davidson et al.,
2012) and here we tested their ability to attenuate cue-primed
reinstatement of alcohol-seeking. NAC serves as a cystine pro-
drug that drives system xc- to export more glutamate while
CEF is an antibiotic that upregulates the expression of both
GLT-1 (Lee et al., 2008) and xCT (Lewerenz et al., 2009) at the
transcriptional level. We also hypothesized the antibiotic cefa-
zolin (CEFAZ), which has been demonstrated to inhibit GABAA
transmission (Yamazaki et al., 2002; Sugimoto et al., 2003), would
attenuate cue-primed alcohol reinstatement. In order to inves-
tigate a possible eﬀect of CEFAZ on glutamate homeostasis, we
tested its ability to attenuate the reinstatement of cocaine-seeking,
a behavior that is dependent on altered glutamate release, clear-
ance and basal levels (for review see Knackstedt and Kalivas,
2009).
Materials and Methods
Animals and Housing
Adult male Sprague-Dawley rats (n = 84), weighing 250–275 g
upon arrival were individually housed in ventilated Plexiglas
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cages in a climate-controlled room on a 12-h reverse light/dark
cycle (lights oﬀ at 9 AM) and given at least 1 week to acclimate
to the individual housing conditions and handling. Rats were
provided ad libitum water throughout the experiment and
were food-deprived to ∼85% of free-feeding weight with a
daily allowance of 20 g of food. Food-restriction generally
increases responding without altering reinstatement rela-
tive to non-restricted controls (Bongiovanni and See, 2008).
Experiment 1 was conducted at the Medical University
of South Carolina and Experiments 2–4 were conducted
at the University of Florida. All procedures were pre-
approved by the Medical University of South Carolina
and University of Florida Institutional Animal Care and
Use Committees and were in accordance with National
Institutes of Health Guide for the Care and Use of Laboratory
Animals.
Operant Chambers and Training
Prior to beginning operant self-administration (Experiments
1–4), animals underwent a single, overnight food-training ses-
sion in the operant chambers where presses on the active
lever resulted in the delivery of food pellets. Operant cham-
bers (Med Associates) were equipped with two retractable levers,
stimulus lights, and tone generators. On the day following
food training, animals were trained to self-administer alco-
hol, cocaine, or food pellets in the operant chamber. For the
food self-administration study (Experiment 3), presses on the
active lever delivered food pellets. For drug self-administration
studies, presses on the active lever activated a pump which
dispensed drug. For alcohol studies (Experiments 1 and 2),
0.1 mL alcohol (20% v/v) was dispensed into a dipper tray;
infrared sensors veriﬁed head entry into the trough area to
consume the alcohol. For the cocaine study (Experiment 4),
0.25 mg cocaine HCl (kindly provided by NIDA) in 0.1 mL
0.9% saline was delivered per infusion. For both cocaine and
alcohol studies, drug delivery was accompanied by the pre-
sentation of discrete cues (a light and 2900 Hz tone) and for
cocaine self-administration, was followed by a timeout (20 s)
during which time presses on the active lever did not yield
drug. Inactive lever presses had no consequences, but were
recorded. For alcohol self-administration, the trough was blot-
ted with a tissue at the end of the session to verify that all
alcohol was consumed. Rats who habitually did not consume
alcohol despite lever presses were eliminated from the exper-
iment (n = 3 for Experiment 1; n = 2 for Experiment 2).
Additionally, three rats that were in ill-health were removed
from Experiments 1 and 2. For both alcohol and cocaine self-
administration studies, animals self-administered drug for a
pre-determined number of days in the operant boxes (26 for
alcohol; 12 for cocaine) regardless of whether drug intake was
stable or not. This method was chosen because we wanted
to prevent animals from self-administering drug for vary-
ing amounts of time which could lead to a wide range of
drug intake. The amount of cocaine consumed during self-
administration has been correlated with later drug-seeking dur-
ing reinstatement tests (e.g., Deroche et al., 1999; Baker et al.,
2001).
Alcohol Self-Administration, Extinction
Training, and Reinstatement Testing
All rats that later self-administered alcohol in the operant cham-
bers were ﬁrst trained to drink with the IAA (e.g., Simms et al.,
2008). This paradigm provides rats with 24-h access to unsweet-
ened 20% alcohol on alternating days (3 days/weeks) with-
out water-deprivation. Animals experienced 12 sessions (over
4 weeks) of the intermittent-access drinking paradigm.
Following exposure to alcohol using the IAA, animals were
trained to self-administer 20% alcohol (v/v) using daily 45 min
training sessions on an FR-1 schedule of reinforcement for 6 days
followed by an FR-3 schedule for 20 daily sessions. This proce-
dure followed that of Simms et al. (2010), with the exception of
using 45 min FR-3 operant sessions in place of 30 min sessions
and replacing the 12 overnight operant sessions with 12 IAA ses-
sions. Extinction training began following the 20th FR-3 session.
During extinction training, presses on the previously active lever
no longer provided drug and cue presentation. Extinction train-
ing lasted a minimum of 10 sessions and until animals reached
the criteria of less than 20 lever responses per session. Once this
criteria was reached, animals underwent a 45 min cue-primed
reinstatement test during which presses on the previously active
lever once again yielded presentation of discrete cues that had
been paired with alcohol delivery (stimulus light, tone and the
sound of the syringe pump activating). In addition, 2 mL of 20%
EtOH was sprinkled on the bedding of the operant chamber to
provide an olfactory cue.
Experiment 1
Here, we tested the ability of chronically administered NAC to
attenuate the cue-primed reinstatement of alcohol-seeking. N-
acetylcysteine (Sigma, 30 or 60 mg/kg IP) or vehicle (VEH; saline
0.3 mL IP) was administered 2 h prior to the last 6–8 extinc-
tion sessions and prior to the reinstatement test (see Figure 1A).
The dose and timing of injections was based on previous studies
demonstrating the ability of 60 mg/kg NAC to restore basal glu-
tamate levels after cocaine and attenuate cocaine reinstatement
when given both acutely prior to testing (Baker et al., 2003) and
chronically during extinction training (Amen et al., 2011) while
a lower dose (33 mg/kg) only partially inhibits cocaine-seeking
(Moussawi et al., 2009). NACworks acutely, within 2 h of admin-
istration, to increase basal glutamate by serving as an exogenous
source of cysteine, which drives system xc- to export more glu-
tamate (Baker et al., 2003), but also alters glutamate homeostasis
when administered daily for 5 or more days (Knackstedt et al.,
2010; Amen et al., 2011). After reaching extinction criteria, the
responding of the NAC-treated animals during a cue- primed
reinstatement trial was compared with VEH-treated animals.
Animals were assigned to receive NAC or VEH treatment in
a counterbalanced manner to ensure no group diﬀerences in
drug self-administration. One animal was excluded from rein-
statement testing (and all data analysis) due to a failure to reach
extinction criteria.
Experiment 2
This experiment was carried out in an identical manner to
Experiment 1, with the exception that CEF (Hospira, 200 mg/kg
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FIGURE 1 | Experimental Methods. (A) Timeline of the experimental
procedure for Experiments 1 and 2. All animals were trained to
self-administer food pellets immediately prior to beginning operant alcohol
self-administration. VEH, NAC, CEF, and CEFAZ treatment commenced on
the last 6–8 days of extinction training. For the NAC experiment, animals
were also injected 2 h prior to the test. (B) Timeline of the experimental
procedure for Experiment 3. All animals were trained to self-administer food
pellets immediately prior to beginning operant alcohol self-administration.
VEH, CEF, and CEFAZ treatment commenced on Day 5 of food
self-administration and continued through Day 12. (C) Timeline of the
procedure for Experiment 4. All animals were trained to self-administer food
pellets immediately prior to beginning operant cocaine self-administration.
VEH and CEFAZ was administered for the last 6–8 extinction sessions and
continued after the cue-primed reinstatement test.
IP), CEFAZ (Sigma, 100 mg/kg IP), or VEH (0.9% saline)
were administered immediately following the last 6–8 extinc-
tion sessions, but not on test day (see Figure 1A). After reach-
ing extinction criteria, the responding of the CEF and CEFAZ-
treated animals during a cue- primed reinstatement trial was
compared with VEH -treated animals. The dose and timing of
CEF injections was based on previously published reports show-
ing that 200 mg/kg eﬀectively attenuates cocaine reinstatement
and restores glutamate homeostasis when given chronically after
extinction sessions for at least 5 days (Knackstedt et al., 2010;
Trantham-Davidson et al., 2012). The dose of CEFAZ was based
on allometric calculations from the maximum human dose rec-
ommended by the manufacturer to the equivalent rat dose of
100 mg/kg maximum and was given after extinction sessions akin
to the administration of CEF.
Food and Sucrose Self-Administration (Experiment 3)
Animals self-administered standard chow pellets (45 mg; Bio-
serv) in the operant chamber using an FR-1 schedule of rein-
forcement for 2 h/day for 12 days. On the 13th day, sucrose
pellets (45 mg; Bio-serv) replaced the standard chow pellets.
Animals received CEF, CEFAZ, or VEH in an identical man-
ner as described for Experiment 2, with the exception that
injections began after the operant session on Day 5 of food
self-administration (see Figure 1B).
Cocaine Self-Administration, Extinction, and
Reinstatement (Experiment 4)
For the implantation of catheters, rats were anesthetized with
ketamine HCl (87.5 mg/kg, IM) and xylazine (5 mg/kg, IM).
Ketorolac (3 mg/kg, IP) was administered before surgery to
provide analgesia. Catheter construction and surgical implan-
tation is described in detail elsewhere (Knackstedt et al., 2014).
Rats recovered 6 days after surgery prior to beginning self-
administration training. Cocaine self-administration was con-
ducted using an FR-1 schedule; sessions lasted 2 h/day and
are described in more detail above. Self-administration contin-
ued until subjects had attained 12 days with a minimum of
10 cocaine infusions and was followed by extinction training.
Animals were either treated with CEFAZ or VEH in manner
identical to that in Experiment 2, immediately following the
last 6–8 extinction sessions (see Figure 1C). Once extinction
criteria was attained, animals were tested for cue- and cocaine-
primed reinstatement (each test lasting 2 h), with tests separated
by 3 days of extinction training. During cue-primed reinstate-
ment, presses on the previously active lever once again yielded
the discrete cues paired with cocaine delivery but no drug was
delivered. During cocaine-primed reinstatement, animals were
injected with 10 mg/kg cocaine (IP) immediately prior to being
placed into the operant chamber; presses on the previously active
lever had no consequences during this test.
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Data Analysis
The alpha level was set at p < 0.05 for all statistical tests,
which were conducted using SPSS software. Active lever presses
during self-administration and extinction components of the
experiment were analyzed with mixed-factorial 2-way analysis
of variances (ANOVAs) test, with time as the repeated mea-
sure. Reinstatement tests were planned comparisons (extinction
vs. test day) and thus were analyzed with paired-sample t-tests.
Independent-sample t-tests were used to compare active lever
presses during reinstatement tests between treatment groups.
Group diﬀerences in food self-administration were examined
using one-way ANOVAs. Outliers were deﬁned as values more
than two standard deviation +/– the mean and were excluded
from further analysis. Groups with outlier values are mentioned
in the Results section.
Results
The Effects of NAC on Cue-Primed
Reinstatement of Alcohol-Seeking
(Experiment 1)
VEH- and NAC-treated groups did not diﬀer in the amount
of alcohol self-administered (Figure 2A). A two-way ANOVA
with repeated measures on Day was computed on the active
lever press data during self-administration and found no sig-
niﬁcant eﬀect of Day [F(19,475) = 1.480, n.s.], or Group
[F(2,25) = 0.080, n.s.]. There was a signiﬁcant Day × Group
interaction [F(19,475) = 2.020, p < 0.01]. Similarly, a two-way
ANOVA was computed on the lever presses during extinction
training (Figure 2B) and revealed a signiﬁcant eﬀect of Day
[F(9,225) = 6.977, p < 0.001], but not Group [F(2,25) = 0.240,
n.s.]. There was not a signiﬁcant Day × Group interaction
[F(18,225) = 0.809, n.s.]. We used paired-sample t-tests to ana-
lyze the data presented in Figure 2C to compare active lever
presses during cue-primed reinstatement to those during the
average of the last 3 days of extinction. Signiﬁcant diﬀerences
were found between extinction and cue-primed reinstatement
for all treatment groups [Veh: t(1,7) = 4.036, p < 0.01; NAC60:
t(1,8) = 4.302, p < 0.01; NAC30: t(1,9) = 3.651, p < 0.05], indi-
cating that neither dose of NAC was able to prevent cue-primed
reinstatement of alcohol-seeking.
The Effects of CEF and CEFAZ on
Cue-Primed Reinstatement of
Alcohol-Seeking (Experiment 2)
Vehicle, CEF, and CEFAZ groups did not diﬀer in the
amount of active lever presses during self-administration
(Figure 3A). A two-way ANOVA with repeated measures
on Day was computed on the active lever presses during
alcohol self-administration (Figure 3A) and revealed a sig-
niﬁcant eﬀect of Day [F(19,380) = 2.612, p < 0.01], but
not Group [F(2,20) = 0.370, n.s.]. There was not a sig-
niﬁcant Day × Group interaction [F(19,380) = 1.277, n.s.].
Similarly, a two-way ANOVA was computed on the num-
ber of lever presses during extinction training (Figure 3B)
and revealed a signiﬁcant eﬀect of Day [F(9,180) = 8.050,
FIGURE 2 | N-acetylcysteine did not attenuate cue-primed
reinstatement of alcohol-seeking. (A) Mean active lever presses during
the FR3 portion of the experiment did not differ between groups. (B) Mean
active lever presses during extinction training did not differ between groups.
(C) N-acetylcysteine did not attenuate cue-primed reinstatement of alcohol-
seeking. *p < 0.05 comparing extinction to test.
p < 0.001], but not Group [F(2,20) = 0.989, n.s.]. There was
not a signiﬁcant Day × Group interaction [F(2,180) = 1.249,
n.s.]. We used paired-sample t-tests to compare active lever
presses during cue-primed reinstatement to those during the
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FIGURE 3 | Ceftriaxone and cefazolin attenuated the reinstatement
alcohol-seeking. (A) Mean active lever presses during the FR3 portion of the
experiment did not differ between groups. (B) Mean active lever presses
during extinction training did not differ between groups. (C) Only
vehicle-treated animals reinstated lever-pressing during a cue-primed
reinstatement test. *p < 0.05 comparing extinction to test.
last 3 days of extinction (Figure 3C). A signiﬁcant diﬀer-
ence between extinction and cue-primed reinstatement was
only observed for vehicle-treated animals [t(1,8) = 2.892,
p < 0.05], indicating that CEF [t(1,6) = 1.3998, n.s.] and CEFAZ
[t(1,6) = 2.090, n.s.] attenuated cue-primed reinstatement of
alcohol-seeking.
CEF and CEFAZ Did Not Alter Food and
Sucrose Self-Administration or Weight
(Experiment 3)
Because CEF and CEFAZ treatment commenced following the
session on Day 5, statistical analyses were conducted only on
the data during the period of antibiotic (or vehicle) treat-
ment (Days 6–12). One animal was excluded from data anal-
ysis because his lever pressing on Day 13 was greater than
two standard deviations from the mean value. A one-ANOVA
was computed on active lever presses during self-administration
and revealed no eﬀect of treatment group [F(2,17) = 2.128,
n.s.; Figure 4A]. We also conducted a two-way ANOVA with
repeated measures on Day and this analysis revealed no sig-
niﬁcant eﬀects [Day: F(6,102) = 1.963, n.s.; Day × Group:
F(12,102) = 1.375, n.s.; Group: F(2,17) = 2.361, n.s.]. A one-
way ANOVA was used to determine if there were group diﬀer-
ences in the number of sucrose pellets earned on Day 13 of the
experiment (Figure 4B) and found no eﬀect [F(2,17) = 1.068,
n.s.]. There was also no diﬀerence in weight over time
between the three treatment groups (Figure 4C). A two-way
RM ANOVA found an eﬀect of Day [F(11,102) = 9.145,
p < 0.001] but no Day × Group interaction [F(12,102) = 2.507,
n.s.] or eﬀect of Group [F(2,17) = 1.924, n.s.] on animal
weight.
CEFAZ Did Not Attenuate the Reinstatement
of Cocaine-Seeking (Experiment 4)
A two-way ANOVA computed on the amount of cocaine intake
(Figure 5A) revealed no group diﬀerences [F(1,12) = 0.357,
n.s.], no eﬀect of Day [F(11,132) = 1.562, n.s.], and no
Day × Group interaction [F(12,132) = 0.453, n.s.]. There
were also no group diﬀerences in extinction training
[F(1,12) = 0.472, n.s.] and no Day × Group interac-
tion [F(12,108) = 0.696, n.s.] but there was an eﬀect
of Day [F(9,108) = 19.076, p < 0.001] as both groups
decreased lever pressing during the course of training
(Figure 5B). Paired-sample t-tests revealed signiﬁcant dif-
ferences between extinction and cue-primed reinstatement
for both CEFAZ [t(1,5) = 2.834, p < 0.05] and vehicle-
treated [t(1,7) = 4.453, p < 0.01] animals (Figure 5C).
Paired-sample t-tests revealed signiﬁcant diﬀerences between
extinction and cocaine-primed reinstatement for both CEFAZ
[t(1,5) = 2.834, p < 0.05] and vehicle-treated [t(1,7) = 2.614,
p < 0.05] animals (Figure 5D). Thus, CEFAZ did not atten-
uate cue- or cocaine-primed reinstatement. Furthermore,
an independent sample t-test showed no lever pressing
diﬀerences between vehicle- and CEFAZ-treated groups
during the cue [t(1,12) = 0.272, n.s.] and cocaine tests
[t(1,12) = 0.269, n.s.].
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FIGURE 4 | Ceftriaxone and cefazolin did not alter the motivation to self-administer regular chow or sucrose pellets. (A) CEF and CEFAZ did not alter
the self-administration of regular chow pellets. (B) CEF and CEFAZ did not alter the mean number of sucrose pellets self-administered. (C) Mean body weight did not
differ between vehicle-, CEF- or CEFAZ-treated rats.
FIGURE 5 | Cefazolin did not attenuate cue- or cocaine-primed
reinstatement of cocaine-seeking. (A) Animals later treated with
vehicle or CEFAZ did not differ in the number of infusions attained
during cocaine self-administration. (B) Vehicle- and CEFAZ-treated
animals did not differ in active lever presses during extinction training.
(C) CEFAZ did not attenuate cue-primed reinstatement. (D) CEFAZ did
not attenuate cocaine-primed reinstatement. *p < 0.05 comparing
extinction to test.
Discussion
Here, we demonstrated that training Sprague-Dawley rodents
to self-administer unsweetened alcohol in the operant cham-
ber can be accomplished using daily training sessions with-
out lengthy (14 h; e.g., Simms et al., 2010) operant sessions
on alternating days. This is the ﬁrst demonstration of such
an eﬀect in the Sprague-Dawley strain. Augier et al. (2014)
recently demonstrated the same eﬀect in Wistar rats. Using
the procedure outlined here (Figure 1A) reduced the time
to complete the experiment by 4 weeks relative to a pro-
cedure utilizing intermittent (MWF) operant sessions (e.g.,
Simms et al., 2010). This represents a signiﬁcant conservation of
lab resources.
We used this operant procedure to investigate the ability
of NAC, CEF, and CEFAZ to attenuate cue-primed reinstate-
ment. Five days of NAC treatment (30 or 60 mg/kg) did not
attenuate cue-primed reinstatement (Figure 2C). We found that
chronic CEF (200 mg/kg) and CEFAZ (100 mg/kg) attenu-
ated cue-primed reinstatement of alcohol-seeking (Figure 3C).
Both NAC and CEF attenuate cocaine and heroin reinstatement
(Baker et al., 2003; Zhou and Kalivas, 2008; Knackstedt et al.,
2010; Reichel et al., 2011; Sondheimer and Knackstedt, 2011;
Shen et al., 2014). Furthermore, both compounds have been doc-
umented to similarly restore glutamate homeostasis in the NAc
following cocaine (see Table 1). Both compounds increase GLT-
1 and system xc-/xCT expression and function (Knackstedt et al.,
2010; Trantham-Davidson et al., 2012), increase basal glutamate
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TABLE 1 | Summary of N-acetylcysteine and ceftriaxone effects on
cocaine-induced adaptations in the nucleus accumbens.
Post-cocaine
adaptation
Compound
N-acetylcysteine Ceftriaxone
Restore (elevate)
basal glutamate
Yes
Baker et al. (2003)
Yes
Trantham-Davidson et al.
(2012)
Prevent glutamate
release during
cocaine relapse
Yes
Baker et al. (2003)
Yes
Trantham-Davidson et al.
(2012)
Increase GLT-1
expression/function
Yes (expression)
Knackstedt et al.
(2010)
function not
assessed
Yes
Knackstedt et al.
(2010),
Trantham-Davidson et al.
(2012)
Increase xCT
expression/system
xc- function
Yes
Baker et al. (2003),
Knackstedt et al.
(2010)
Yes
Knackstedt et al.
(2010),
Trantham-Davidson et al.
(2012)
Stimulate mGluR2/3
function
Yes
Moussawi et al.
(2011)
Not yet assessed
Normalize potentiated
accumbens synapses
Yes
Moussawi et al.
(2011)
Yes
Trantham-Davidson et al.
(2012)
levels (Baker et al., 2003; Trantham-Davidson et al., 2012), and
normalize potentiated glutamate synapses (Moussawi et al., 2011;
Trantham-Davidson et al., 2012). Because CEF and NAC modu-
late post-cocaine glutamate homeostasis in similar manner, and
the present results reveal a dissociation between the ability of
the compounds to attenuate alcohol reinstatement, CEF and
CEFAZ likely attenuate alcohol reinstatement via a glutamate-
independent mechanism.
Cefazolin has been shown to reduce GABAA transmission
(Yamazaki et al., 2002; Sugimoto et al., 2003). Positive allosteric
modulation of GABAA enhances reinstatement of alcohol-
seeking (Finn et al., 2008; Ramaker et al., 2014) and thus a reduc-
tion in GABA transmission by CEFAZ may be the mechanism
of action by which it reduces alcohol reinstatement. CEF has not
been fully evaluated for its ability to alter GABA transmission
although one report exists showing that it does not alter GABAA
receptor binding in the hippocampus or frontal and parietal cor-
tices (Inui et al., 2013). CEFAZ has not been demonstrated to
alter glutamate transmission: it does not alter NMDA function
(Yamazaki et al., 2002; Sugimoto et al., 2003) and was not deter-
mined to potently induce GLT-1 expression as do CEF and peni-
cillin (Rothstein et al., 2005). The data presented in Figures 5C,D
provide evidence that CEFAZ does not alter cue- or cocaine-
primed reinstatement of cocaine-seeking. Thus, the mechanism
by which CEFAZ attenuates alcohol reinstatement likely does not
involve modulation of glutamate neurotransmission in the NAs.
Ceftriaxone and CEFAZ are antibiotics and have the poten-
tial to produce gastrointestinal distress upon chronic admin-
istration. Oral alcohol self-administration in rodents and even
alcohol-seeking during cue-primed reinstatements tests may be
impacted by this side-eﬀect. Thus we sought to determine the
eﬀects of these antibiotics on the operant self-administration of
regular chow and sucrose pellets. We found no eﬀect of either
antibiotic on the self-administration of chow (Figure 4A) or
sucrose (Figure 4B) pellets or on body weight during the course
of CEF and CEFAZ injections (Figure 4C). These ﬁndings are
in agreement with those of Ward et al. (2011) who found no
eﬀect of CEF on the self-administration of sweet food in mice.
Interestingly, the chronic administration of NAC, which did not
attenuate alcohol-seeking here, has been demonstrated to reduce
operant self-administration of regular chow (Ramirez-Niño et al.,
2013). Thus, we can conclude that the ability of CEF and CEFAZ
to attenuate cue-primed alcohol-seeking is likely not dependent
on any gastrointestinal side-eﬀects of these compounds.
Because CEFAZ had no impact on cocaine reinstatement
(Figure 5C), it may not be capable of restoring glutamate home-
ostasis after cocaine. Thus, this is not likely the mechanism by
which CEF and CEFAZ attenuate cue-primed reinstatement of
alcohol-seeking. In support of this, NAC, which does alter gluta-
mate homeostasis, did not attenuate cue-primed alcohol-seeking.
This conclusion is surprising in light of the evidence support-
ing glutamate signaling in this behavior. In alcohol-preferring (P)
rats, CEF reduces the consumption of alcohol acutely and after
a period of withdrawal (Sari et al., 2013; Alhaddad et al., 2014).
In P rats, the ability of CEF to modulate alcohol-seeking was
accompanied by increases in GLT-1 and xCT (Sari et al., 2013;
Alhaddad et al., 2014). These results indicate that the modula-
tion of glutamate homeostasis may be the mechanism by which
CEF attenuates alcohol consumption, at least in P rats. However,
the increased expression of these proteins was not shown to
be the mechanism by which CEF exerted its behavioral eﬀects.
An alternative explanation for the failure of NAC to attenuate
alcohol reinstatement in the present manuscript is that the oper-
ationalization of the alcohol-seeking response may have altered
the underlying neurobiology of alcohol-seeking, rendering the
manipulation of GLT-1 and xCT (and thereby glutamate levels)
ineﬀective at preventing reinstatement.
The lack of an eﬀect of NAC on alcohol-seeking here does not
discount the involvement of glutamate in alcohol reinstatement.
Antagonism of the post-synaptic mGluR5 and AMPA receptors
attenuates cue-induced reinstatement (Backstrom and Hyytia,
2004; Backstrom et al., 2004; Sanchis-Segura et al., 2006;
Sinclair et al., 2012). Stimulating the pre-synaptic glutamate
autoreceptor mGluR2/3 also attenuates cue-induced rein-
statement of alcohol-seeking (Zhao et al., 2006), presumably
by decreasing pre-synaptic glutamate release. While both
cocaine and alcohol reinstatement are driven by synaptic glu-
tamate release in the NA core during the reinstatement event
(McFarland et al., 2003; Gass et al., 2011) and NAC and CEF
attenuate that increase during cocaine reinstatement (Baker et al.,
2003; Trantham-Davidson et al., 2012), NAC (and potentially
CEF) may not be able to attenuate glutamate release during
alcohol reinstatement. The reason for this may be that cocaine
and alcohol have opposite eﬀects on basal glutamate levels
in the NA core. Cocaine decreases (Baker et al., 2003) while
alcohol increases (Melendez et al., 2005; Griﬃn Iii et al., 2013)
basal glutamate levels. Both NAC and CEF increase basal
glutamate levels after cocaine but not in drug-naïve animals
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(Baker et al., 2003; Trantham-Davidson et al., 2012). After NAC
treatment, this increased basal glutamate derived from system
xc- restores tone on mGluR2/3 autoreceptors (Moussawi et al.,
2011), thereby restoring the ability of these receptors to exert
negative feedback on glutamate release during reinstatement.
It is possible that increased basal glutamate following alcohol
also causes a failure in mGluR2/3 signaling that is insensitive
to NAC treatment. The eﬀects of CEF on mGluR2/3 function
have not yet been investigated (see Table 1). Future experiments
examining basal glutamate levels 2–3 weeks after cessation of
alcohol self-administration in combination with NAC and CEF
would provide valuable data regarding the potential value in
manipulating basal glutamate to treat alcohol relapse.
Overall, these results indicate that training Sprague-
Dawley rats to self-administer alcohol in the operant chamber
can be accomplished without sucrose fading and by using
daily training sessions without lengthy operant sessions.
We found that modulating glutamate homeostasis likely
will not represent a successful treatment strategy for pre-
venting relapse to alcohol-seeking. Future studies should
investigate GABA modulation as a potential mechanism of
action for CEF and as a method of attenuating alcohol
relapse.
Acknowledgments
This project was funded by a pilot award from the Charleston
Alcohol Research Center (P50 AA010761) and NIDA R01
DA033436, both awarded to LK.
References
Alhaddad, H., Das, S. C., and Sari, Y. (2014). Eﬀects of CEF on alcohol intake:
a possible role for xCT and GLT-1 isoforms modulation of glutamate lev-
els in P rats. Psychopharmacology 231, 4049–4057. doi: 10.1007/s00213-014-
3545-y
Amen, S. L., Piacentine, L. B., Ahmad, M. E., Li, S. J., Mantsch, J. R., Risinger, R. C.,
et al. (2011). RepeatedN-acetylcysteine reduces cocaine seeking in rodents and
craving in cocaine-dependent humans. Neuropsychopharmacology 36, 871–878.
doi: 10.1038/npp.2010.226
Augier, E., Flanigan, M., Dulman, R. S., Pincus, A., Schank, J. R., Rice, K. C.,
et al., (2014). Wistar rats acquire and maintain self-administration of 20%
ethanol without water deprivation, saccharin/sucrose fading, or extended
access training. Psychopharmacology 231, 4561–4568. doi: 10.1007/s00213-014-
3605-3
Avena, N. M., Rada, P., and Hoebel, B. G. (2008). Evidence for sugar addic-
tion: behavioral and neurochemical eﬀects of intermittent, excessive sugar
intake. Neurosci. Biobehav. Rev. 32, 20–39. doi: 10.1016/j.neubiorev.2007.
04.019
Backstrom, P., Bachteler, D., Koch, S., Hyytia, P., and Spanagel, R.
(2004). mGluR5 antagonist MPEP reduces ethanol-seeking and relapse
behavior. Neuropsychopharmacology 29, 921–928. doi: 10.1038/sj.npp.
1300381
Backstrom, P., and Hyytia, P. (2004). Ionotropic glutamate receptor antag-
onists modulate cue-induced reinstatement of ethanol-seeking behavior.
Alcohol. Clin. Exp. Res. 28, 558–565. doi: 10.1097/01.ALC.0000122101.
13164.21
Baker, D. A., McFarland, K., Lake, R. W., Shen, H., Tang, X. C., Toda, S.,
et al. (2003). Neuroadaptations in cystine-glutamate exchange underlie cocaine
relapse. Nat. Neurosci. 6, 743–749. doi: 10.1038/nn1069
Baker, D. A., Tran-Nguyen, T. L., Fuchs, R. A., and Neisewander, J. L.
(2001). Inﬂuence of individual diﬀerences and chronic ﬂuoxetine treatment
on cocaine-seeking behavior in rats. Psychopharmacology 155, 18–26. doi:
10.1007/s002130000676
Baker, D. A., Xi, Z. X., Shen, H., Swanson, C. J., and Kalivas, P. W. (2002). The
origin and neuronal function of in vivo nonsynaptic glutamate. J. Neurosci. 22,
9134–9141.
Bongiovanni, M., and See, R. E. (2008). A comparison of the eﬀects of diﬀer-
ent operant training experiences and dietary restriction on the reinstatement
of cocaine-seeking in rats. Pharmacol. Biochem. Behav. 89, 227–233. doi:
10.1016/j.pbb.2007.12.019
Carrillo, J., Howard, E. C., Moten, M., Houck, B. D., Czachowski, C. L., and
Gonzales, R. A. (2008). A 3-day exposure to 10% ethanol with 10% sucrose
successfully initiates ethanol self-administration. Alcohol 42, 171–178. doi:
10.1016/j.alcohol.2008.01.005
Colantuoni, C., Rada, P., McCarthy, J., Patten, C., Avena, N. M., Chadeayne, A.,
et al. (2002). Evidence that intermittent, excessive sugar intake causes
endogenous opioid dependence. Obes. Res. 10, 478–488. doi: 10.1038/oby.
2002.66
Deroche, V., Le Moal, M., and Piazza, P. V. (1999). Cocaine self-administration
increases the incentive motivational properties of the drug in rats. Eur. J.
Neurosci. 11, 2731–2736. doi: 10.1046/j.1460-9568.1999.00696.x
Epstein, D. H., Preston, K. L., Stewart, J., Shaham, Y. (2006). Toward a model
of drug relapse: an assessment of the validity of the reinstatement procedure.
Psychopharmacology (Berl) 189, 1–16. doi: 10.1007/s00213-006-0529-6
Finn, D. A., Mark, G. P., Fretwell, A. M., Gililland-Kaufman, K. R., Strong, M. N.,
and Ford, M. M. (2008). Reinstatement of ethanol and sucrose seeking by
the neurosteroid allopregnanolone in C57BL/6 mice. Psychopharmacology 201,
423–433. doi: 10.1007/s00213-008-1303-8
Gass, J. T., Sinclair, C. M., Cleva, R. M., Widholm, J. J., and Olive, M. F. (2011).
Alcohol-seeking behavior is associated with increased glutamate transmission
in basolateral amygdala and nucleus accumbens as measured by glutamate-
oxidase-coated biosensors. Addict. Biol. 16, 215–228. doi: 10.1111/j.1369-
1600.2010.00262.x
Griﬃn, W. C. III., Haun, H. L., Hazelbaker, C. L., Ramachandra, V. S., and
Becker, H. C. (2013). Increased extracellular glutamate in the nucleus
accumbens promotes excessive ethanol drinking in ethanol depen-
dent mice. Neuropsychopharmacology 39, 707–717. doi: 10.1038/npp.
2013.256
Heilig, M., and Egli, M. (2006). Pharmacological treatment of alcohol dependence;
target symptoms and target mechanisms. Pharmacol. Ther. 111, 855–876. doi:
10.1016/j.pharmthera.2006.02.001
Inui, T., Alessandri, B., Heimann, A., Nishimura, F., Frauenknecht, K.,
Sommer, C., et al. (2013). Neuroprotective eﬀect of CEF on the penum-
bra in a rat venous ischemia model. Neuroscience 242, 1–10. doi:
10.1016/j.neuroscience.2013.03.018
Janak, P. H., and Michael Gill, T. (2003). Comparison of the eﬀects of allo-
pregnanolone with direct GABAergic agonists on ethanol self-administration
with and without concurrently available sucrose. Alcohol 30, 1–7. doi:
10.1016/S0741-8329(03)00068-5
Kalivas, P. W., Lalumiere, R. T., Knackstedt, L., and Shen H. (2009). Glutamate
transmission in addiction. Neuropharmacology 56(Suppl. 1), 169–173. doi:
10.1016/j.neuropharm.2008.07.011
Kenna, G. A., McGeary, J. E., and Swift, R. M. (2004). Pharmacotherapy, phar-
macogenomics, and the future of alcohol dependence treatment, Part 2. Am. J.
Health Syst. Pharm. 61, 2380–2388.
Knackstedt, L. A., and Kalivas, P. W. (2009). Glutamate and reinstatement. Curr.
Opin. Pharmacol. 9, 59–64. doi: 10.1016/j.coph.2008.12.003
Knackstedt, L. A., Melendez, R. I., and Kalivas, P. W. (2010). CEF restores gluta-
mate homeostasis and prevents relapse to cocaine seeking. Biol. Psychiatry 67,
81–84. doi: 10.1016/j.biopsych.2009.07.018
Knackstedt, L. A., Trantham-Davidson, H., and Schwendt, M. (2014). The role
of ventral and dorsal striatum mGluR5 in relapse to cocaine-seeking and
extinction learning. Addict. Biol. 19, 87–101. doi: 10.1111/adb.12061
Koob, G. F., and Weiss, F. (1990). Pharmacology of drug self-administration.
Alcohol 7, 193–197. doi: 10.1016/0741-8329(90)90004-V
Lee, S. G., Su, Z. Z., Emdad, L., Gupta, P., Sarkar, D., Borjabad, A., et al. (2008).
Mechanism of ceftriaxone induction of excitatory amino acid transporter-2
Frontiers in Pharmacology | www.frontiersin.org 9 March 2015 | Volume 6 | Article 44
Weiland et al. Ceftriaxone and cefazolin attenuate the reinstatement of alcohol-seeking
expression and glutamate uptake in primary human astrocytes. J. Biol. Chem.
283, 13116–3123. doi: 10.1074/jbc.M707697200
Lewerenz, J., Albrecht, P., Tien, M. L., Henke, N., Karumbayaram, S., Kornblum,
H. I., et al. (2009). Induction of Nrf2 and xCT are involved in the action of the
neuroprotective antibiotic ceftriaxone in vitro. J. Neurochem. 111, 332–343. doi:
10.1111/j.1471-4159.2009.06347.x
McBride, W. J., and Li, T. K. (1998). Animal models of alcoholism: neurobiology
of high alcohol-drinking behavior in rodents. Crit. Rev. Neurobiol. 12, 339–369.
doi: 10.1615/CritRevNeurobiol.v12.i4.40
McFarland, K., Lapish, C. C., and Kalivas, P. W. (2003). Prefrontal glu-
tamate release into the core of the nucleus accumbens mediates
cocaine-induced reinstatement of drug-seeking behavior. J. Neurosci. 23,
3531–3537.
Meisch, R. A., and Thompson, T. (1972). Ethanol intake during schedule-
induced polydipsia. Physiol. Behav. 8, 471–475. doi: 10.1016/0031-9384(72)
90331-9
Melendez, R. I., Hicks, M. P., Cagle, S. S., and Kalivas, P. W. (2005).
Ethanol exposure decreases glutamate uptake in the nucleus accumbens.
Alcohol. Clin. Exp. Res. 29, 326–333. doi: 10.1097/01.ALC.0000156086.65
665.4D
Moussawi, K., Pacchioni, A., Moran, M., Olive, M. F., Gass, J. T., Lavin, A.,
et al. (2009). N-Acetylcysteine reverses cocaine-induced metaplasticity. Nat.
Neurosci. 12, 182–189. doi: 10.1038/nn.2250
Moussawi, K., Zhou, W., Shen, H., Reichel, C. M., See, R. E., Carr, D. B.,
et al. (2011). Reversing cocaine-induced synaptic potentiation provides endur-
ing protection from relapse. Proc. Natl. Acad. Sci. U.S.A. 108, 385–390. doi:
10.1073/pnas.1011265108
Nie, H., and Janak, P. H. (2003). Comparison of reinstatement of ethanol-
and sucrose-seeking by conditioned stimuli and priming injections of allo-
pregnanolone after extinction in rats. Psychopharmacology 168, 222–228. doi:
10.1007/s00213-003-1468-0
NIH. (2006). “National epidemiologic survey on alcohol and related conditions:
2001–2002. Alcohol use and alcohol use disorders in the United States,” in
Alcohol Epidemiologic Data Reference Manual, Vol. 8 (Bethesda, MD: National
Institute on Alcohol Abuse and Alcoholism).
Pinel, J. P., and Huang, E. (1976). Eﬀects of periodic withdrawal on ethanol and
saccharin selection in rats. Physiol. Behav. 16, 693–698. doi: 10.1016/0031-
9384(76)90238-9
Ramaker, M. J., Ford, M. M., Phillips, T. J., and Finn, D. A. (2014).
Diﬀerences in the reinstatement of ethanol seeking with ganaxolone and
gaboxadol. Neuroscience 272, 180–187. doi: 10.1016/j.neuroscience.2014.
04.065
Ramirez-Niño, A. M., D’Souza, M. S., and Markou, A. (2013). N-acetylcysteine
decreased nicotine self-administration and cue-induced reinstatement of nico-
tine seeking in rats: comparison with the eﬀects of N-acetylcysteine on
food responding and food seeking. Psychopharmacology 225, 473–482. doi:
10.1007/s00213-012-2837-3
Reichel, C. M., Moussawi, K., Do, P. H., Kalivas, P. W., and See, R. E.
(2011). Chronic N-acetylcysteine during abstinence or extinction after
cocaine self-administration produces enduring reductions in drug
seeking. J. Pharmacol. Exp. Ther. 337, 487–493. doi: 10.1124/jpet.111.
179317
Rothstein, J. D., Patel, S., Regan, M. R., Haenggeli, C., Huang, Y. H., Bergles,
D. E., et al. (2005). Beta-lactam antibiotics oﬀer neuroprotection by increas-
ing glutamate transporter expression. Nature 433, 73–77. doi: 10.1038/nature
03180
Samson, H. H. (1986). Initiation of ethanol reinforcement using
a sucrose-substitution procedure in food- and water-sated rats.
Alcohol. Clin. Exp. Res. 10, 436–442. doi: 10.1111/j.1530-0277.1986.tb
05120.x
Samson, H. H., Files, F. J., Denning, C., and Marvin, S. (1998). Comparison of
ethanol-preferring and nonpreferring selectively bred rat lines. I. Ethanol ini-
tiation and limited access operant self-administration. Alcohol. Clin. Exp. Res.
22, 2133–2146. doi: 10.1111/j.1530-0277.1998.tb05927.x
Samson, H. H., Sharpe, A. L., and Denning, C. (1999). Initiation of ethanol
self-administration in the rat using sucrose substitution in a sipper-
tube procedure. Psychopharmacology 147, 274–279. doi: 10.1007/s002130
051167
Samson, H. H., Tolliver, G. A., Pfeﬀer, A. O., Sadeghi, K. G., and Mills, F. G.
(1987). Oral ethanol reinforcement in the rat: eﬀect of the partial inverse ben-
zodiazepine agonist RO15-4513. Pharmacol. Biochem. Behav. 27, 517–519. doi:
10.1016/0091-3057(87)90357-1
Sanchis-Segura, C., Borchardt, T., Vengeliene, V., Zghoul, T., Bachteler, D.,
Gass, P., et al. (2006). Involvement of the AMPA receptor GluR-C subunit
in alcohol-seeking behavior and relapse. J. Neurosci. 26, 1231–1238. doi:
10.1523/JNEUROSCI.4237-05.2006
Sari, Y., Sreemantula, S. N., Lee, M. R., and Choi, D. S. (2013). CEF treat-
ment aﬀects the levels of GLT1 and ENT1 as well as ethanol intake in
alcohol-preferring rats. J. Mol. Neurosci. 51, 779–787. doi: 10.1007/s12031-013-
0064-y
Shen, H. W., Scoﬁeld, M. D., Boger, H., Hensley, M., and Kalivas, P. W. (2014).
Synaptic glutamate spillover due to impaired glutamate uptake mediates
heroin relapse. J. Neurosci. 34, 5649–5657. doi: 10.1523/JNEUROSCI.4564-
13.2014
Simms, J. A., Bito-Onon, J. J., Chatterjee, S., and Bartlett, S. E. (2010).
Long-Evans rats acquire operant self-administration of 20% ethanol without
sucrose fading. Neuropsychopharmacology 35, 1453–1463. doi: 10.1038/npp.
2010.15
Simms, J. A., Steensland, P., Medina, B., Abernathy, K. E., Chandler, L. J., Wise, R.,
et al. (2008). Intermittent access to 20% ethanol induces high ethanol consump-
tion in Long-Evans and Wistar rats. Alcohol. Clin. Exp. Res. 32, 1816–1823. doi:
10.1111/j.1530-0277.2008.00753.x
Sinclair, C. M., Cleva, R. M., Hood, L. E., Olive, M. F., and Gass, J. T. (2012).
mGluR5 receptors in the basolateral amygdala and nucleus accumbens regulate
cue-induced reinstatement of ethanol-seeking behavior. Pharmacol. Biochem.
Behav. 101, 329–335. doi: 10.1016/j.pbb.2012.01.014
Sondheimer, I., and Knackstedt, L. A. (2011). CEF prevents the induction of
cocaine sensitization and produces enduring attenuation of cue- and cocaine-
primed reinstatement of cocaine-seeking. Behav. Brain Res. 225, 252–258. doi:
10.1016/j.bbr.2011.07.041
Soyka, M., and Roesner, S. (2006). New pharmacological approaches for the
treatment of alcoholism. Expert Opin. Pharmacother. 7, 2341–2353. doi:
10.1517/14656566.7.17.2341
Sugimoto, M., Uchida, I., Mashimo, T., Yamazaki, S., Hatano, K., Ikeda, F., et al.
(2003). Evidence for the involvement of GABA(A) receptor blockade in con-
vulsions induced by cephalosporins. Neuropharmacology 45, 304–314. doi:
10.1016/S0028-3908(03)00188-6
Trantham-Davidson, H., LaLumiere, R. T., Reissner, K. J., Kalivas, P. W.,
and Knackstedt, L. A. (2012). CEF normalizes nucleus accumbens synap-
tic transmission, glutamate transport, and export following cocaine self-
administration and extinction training. J. Neurosci. 32, 12406–12410. doi:
10.1523/JNEUROSCI.1976-12.2012
Vacca, G., Serra, S., Brunetti, G., Carai, M. A., Samson, H. H., Gessa, G. L.,
et al. (2002). Operant self-administration of ethanol in sardinian alcohol-
preferring rats. Alcohol. Clin. Exp. Res. 26, 1678–1685. doi: 10.1111/j.1530-
0277.2002.tb02470.x
Walker, B. M., and Koob, G. F. (2007). The gamma-aminobutyric acid-B recep-
tor agonist baclofen attenuates responding for ethanol in ethanol-dependent
rats. Alcohol. Clin. Exp. Res. 31, 11–18. doi: 10.1111/j.1530-0277.2006.
00259.x
Walker, B. M., Rasmussen, D. D., Raskind, M. A., and Koob, G. F. (2008). Alpha
1-noradrenergic receptor antagonism blocks dependence-induced increases
in responding for ethanol. Alcohol 42, 91–97. doi: 10.1016/j.alcohol.2007.
12.002
Ward, S. J., Rasmussen, B. A., Corley, G., Henry, C., Kim, J. K., Walker,
E. A., et al. (2011). Beta-lactam antibiotic decreases acquisition of and
motivation to respond for cocaine, but not sweet food, in C57Bl/6
mice. Behav. Pharmacol. 22, 370–373. doi: 10.1097/FBP.0b013e3283
473c10
Wayner, M. J., and Greenberg, I. (1972). Eﬀects of hypothalamic
stimulation, acclimation and periodic withdrawal on ethanol con-
sumption. Physiol. Behav. 9, 737–740. doi: 10.1016/0031-9384(72)
90043-1
Wise, R. A. (1973). Voluntary ethanol intake in rats following exposure
to ethanol on various schedules. Psychopharmacologia 29, 203–210. doi:
10.1007/BF00414034
Frontiers in Pharmacology | www.frontiersin.org 10 March 2015 | Volume 6 | Article 44
Weiland et al. Ceftriaxone and cefazolin attenuate the reinstatement of alcohol-seeking
Yamazaki, S., Mochizuki, Y., Terai, T., Sugimoto,M., Uchida, I., Matsuoka, N., et al.
(2002). Intracerebroventricular injection of the antibiotic cefoselis produces
convulsion in mice via inhibition of GABA receptors. Pharmacol. Biochem.
Behav. 74, 53–59. doi: 10.1016/S0091-3057(02)00947-4
Zhao, Y., Dayas, C. V., Aujla, H., Baptista, M. A., Martin-Fardon, R., and
Weiss, F. (2006). Activation of group II metabotropic glutamate receptors
attenuates both stress and cue-induced ethanol-seeking and modulates c-fos
expression in the hippocampus and amygdala. J. Neurosci. 26, 9967–9974. doi:
10.1523/JNEUROSCI.2384-06.2006
Zhou, W., and Kalivas, P. W. (2008). N-acetylcysteine reduces extinction
responding and induces enduring reductions in cue- and heroin-induced
drug-seeking. Biol. Psychiatry 63, 338–340. doi: 10.1016/j.biopsych.2007.
06.008
Conflict of Interest Statement: The Reviewer Jamie Peters declares that, despite
being aﬃliated to the same institution as the author Ana Weiland, the review pro-
cess was handled objectively and no conﬂict of interest exists. The authors declare
that the research was conducted in the absence of any commercial or ﬁnancial
relationships that could be construed as a potential conﬂict of interest.
Copyright © 2015 Weiland, Garcia and Knackstedt. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided
the original author(s) or licensor are credited and that the original publica-
tion in this journal is cited, in accordance with accepted academic practice. No
use, distribution or reproduction is permitted which does not comply with these
terms.
Frontiers in Pharmacology | www.frontiersin.org 11 March 2015 | Volume 6 | Article 44
